Clinical Trial Update: Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

View source ↗

Summary

This real-world study evaluated the activity and safety of fostamatinib in consecutive adults with immune thrombocytopenia, including chronic and refractory cas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: ITP - Immune Thrombocytopenia, Chronic ITP | Status: COMPLETED